NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$276.7m

Last Updated

2021/05/11 23:08 UTC

Data Sources

Company Financials +

Executive Summary

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. More Details


Snowflake Analysis

Excellent balance sheet with solid track record.


Similar Companies

Share Price & News

How has Sharps Compliance's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: SMED's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

1.0%

SMED

3.3%

US Healthcare

-1.2%

US Market


1 Year Return

153.6%

SMED

43.2%

US Healthcare

48.3%

US Market

Return vs Industry: SMED exceeded the US Healthcare industry which returned 43.2% over the past year.

Return vs Market: SMED exceeded the US Market which returned 48.3% over the past year.


Shareholder returns

SMEDIndustryMarket
7 Day1.0%3.3%-1.2%
30 Day22.0%8.8%0.2%
90 Day12.3%17.3%1.6%
1 Year153.6%153.6%45.0%43.2%50.8%48.3%
3 Year321.2%321.2%63.4%56.6%62.0%51.9%
5 Year285.4%285.4%111.3%95.2%126.9%101.7%

Long-Term Price Volatility Vs. Market

How volatile is Sharps Compliance's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sharps Compliance undervalued compared to its fair value and its price relative to the market?

34.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SMED ($16.38) is trading below our estimate of fair value ($25.09)

Significantly Below Fair Value: SMED is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SMED is poor value based on its PE Ratio (27.1x) compared to the US Healthcare industry average (23.6x).

PE vs Market: SMED is poor value based on its PE Ratio (27.1x) compared to the US market (20.2x).


Price to Earnings Growth Ratio

PEG Ratio: SMED's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: SMED is overvalued based on its PB Ratio (7x) compared to the US Healthcare industry average (3.6x).


Future Growth

How is Sharps Compliance forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

-4.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SMED's earnings are forecast to decline over the next 3 years (-4.6% per year).

Earnings vs Market: SMED's earnings are forecast to decline over the next 3 years (-4.6% per year).

High Growth Earnings: SMED's earnings are forecast to decline over the next 3 years.

Revenue vs Market: SMED's revenue (4.7% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: SMED's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SMED's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Sharps Compliance performed over the past 5 years?

72.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SMED has a high level of non-cash earnings.

Growing Profit Margin: SMED's current net profit margins (14.2%) are higher than last year (1.2%).


Past Earnings Growth Analysis

Earnings Trend: SMED's earnings have grown significantly by 72.7% per year over the past 5 years.

Accelerating Growth: SMED's earnings growth over the past year (1586.6%) exceeds its 5-year average (72.7% per year).

Earnings vs Industry: SMED earnings growth over the past year (1586.6%) exceeded the Healthcare industry 58.4%.


Return on Equity

High ROE: SMED's Return on Equity (25.6%) is considered high.


Financial Health

How is Sharps Compliance's financial position?


Financial Position Analysis

Short Term Liabilities: SMED's short term assets ($39.5M) exceed its short term liabilities ($18.8M).

Long Term Liabilities: SMED's short term assets ($39.5M) exceed its long term liabilities ($12.1M).


Debt to Equity History and Analysis

Debt Level: SMED's debt to equity ratio (16.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if SMED's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: SMED's debt is well covered by operating cash flow (102.9%).

Interest Coverage: SMED's interest payments on its debt are well covered by EBIT (61.2x coverage).


Balance Sheet


Dividend

What is Sharps Compliance current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SMED's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SMED's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SMED's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.5yrs

Average management tenure


CEO

David Tusa (60 yo)

10.67yrs

Tenure

US$371,181

Compensation

Mr. David P. Tusa, CPA, has been the President of Sharps Compliance Corp. since June 14, 2010 and as its Chief Executive Officer since September 30, 2010. Mr. Tusa served as the Chief Financial Officer of ...


CEO Compensation Analysis

Compensation vs Market: David's total compensation ($USD371.18K) is below average for companies of similar size in the US market ($USD1.02M).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SMED's management team is seasoned and experienced (6.5 years average tenure).


Board Members

Experienced Board: SMED's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SMED insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.3%.


Top Shareholders

Company Information

Sharps Compliance Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sharps Compliance Corp.
  • Ticker: SMED
  • Exchange: NasdaqCM
  • Founded: 1992
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$276.667m
  • Shares outstanding: 16.89m
  • Website: https://www.sharpsinc.com

Number of Employees


Location

  • Sharps Compliance Corp.
  • 9220 Kirby Drive
  • Suite 500
  • Houston
  • Texas
  • 77054
  • United States

Listings


Biography

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/11 23:08
End of Day Share Price2021/05/11 00:00
Earnings2021/03/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.